Federal Act
on Controlling Communicable Human Diseases
(Epidemics Act, EpidA)

English is not an official language of the Swiss Confederation. This translation is provided for information purposes only and has no legal force.

of 28 September 2012 (Status as of 18 December 2021)


Open article in different language:  DE  |  FR  |  IT
Art. 51 Financial assistance for manufacturing therapeutic products

1 The Con­fed­er­a­tion may provide fin­an­cial as­sist­ance for man­u­fac­tur­ing thera­peut­ic products un­der Art­icle 44 in Switzer­land if sup­plies to the pop­u­la­tion in spe­cial or ex­traordin­ary situ­ations can­not oth­er­wise be guar­an­teed.

2 It may provide the fin­an­cial as­sist­ance with­in the lim­its of the au­thor­ised budget in the form of ba­sic con­tri­bu­tions, in­vest­ment con­tri­bu­tions or pro­ject-re­lated con­tri­bu­tions.

3 It may make the con­tri­bu­tions provided the man­u­fac­turer:

a.
is proven to have the know­ledge and abil­ity to de­vel­op or pro­duce the thera­peut­ic products con­cerned;
b.
un­der­takes to man­u­fac­ture the thera­peut­ic products in Switzer­land; and
c.
guar­an­tees to pri­or­it­ise the sup­ply of such thera­peut­ic products to the au­thor­it­ies in spe­cial or ex­traordin­ary situ­ations.

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden